Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
Abroad (travel likely)RecruitingPHASE4
Conditions
End Stage Renal Disease on Dialysis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Yale University, New Haven, Connecticut, United States
Contact: Study coordinator (Veena Rao, PhD)
Study leads
Jeffrey Testani, MD
Principal Investigator
Yale University